Sab Biotherapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Sab Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sab Biotherapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sab Biotherapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $735k | 366k | 2.01 |
| 2025-06-30 | $494k | 282k | 1.75 |
| 2025-03-31 | $375k | 278k | 1.35 |
| 2024-12-31 | $1.1M | 277k | 3.82 |
| 2024-09-30 | $746k | 276k | 2.70 |
| 2024-06-30 | $857k | 276k | 3.10 |
| 2024-03-31 | $801k | 176k | 4.54 |